HEALTHYPEPTIDESPrecision · Purity · Research
Peptides from metabolic regulation research, including incretin analogues such as retatrutide.
Metabolic peptide research is currently dominated by incretin analogues: molecules acting on receptors involved in regulating glucose and energy balance. The field has moved from molecules engaging one receptor to molecules engaging two or three at once.
That progression is precisely what gives retatrutide its place in the literature. Semaglutide engages one receptor, tirzepatide two, retatrutide three — GLP-1, GIP and the glucagon receptor. Research concentrates on how those signalling routes interact.
The difference in registration within this category matters: semaglutide and tirzepatide are authorised medicines in the European Union; retatrutide is not. We supply laboratory research material only.
The same applies to every peptide in this category: the documentation decides whether the material is usable.
Everything in this category is supplied for in-vitro laboratory research only. Not for human or animal consumption, not for diagnostic or therapeutic use. Not medical advice.
